Obesity and Acid Reflux: Obesity can increase the chance of developing acid reflux
Fig.1 GLP-1 structure diagram GLP-1 drugs on market Current GLP-1 drugs available on market include benaglutide, exenatide, liraglutide, lixisenatide, PLGA-encapsulated long-acting exenatide, albiglutide, dulaglutide, Semaglutide, polyethylene glycol loxenatide injection, and oral semaglutide
Tirzepatide is a dual GIP and GLP-1 receptor agonist, while semaglutide is a selective GLP-1 receptor agonist
GHK-Cu (Copper Tripeptide-1): A naturally occurring copper-binding tripeptide composed of glycine, histidine and lysine bound to copper ions, studied for its influence on gene expression related to collagen synthesis, tissue repair and antioxidant defence mechanisms
Related Medications Mounjaro (tirzepatide) Wegovy (semaglutide) Ozempic (semaglutide) Rybelsus (semaglutide) Trulicity (dulaglutide) Victoza (liraglutide) Saxenda (liraglutide) Contrave (naltrexone HCl and bupropion HCl) Qsymia (phentermine and topiramate extended-release) Xelstrym (dextroamphetamine) Sources Medscape Zepbound Prescribing Information Zepbound Medication Guide Eli Lilly Centers for Disease Control and Prevention (2022)
Consult your veterinarian or an equine nutritional professional to learn if ALCAR may be a valuable addition to your horses diet